| ENT* | Digestive | Respiratory | MS | GU |
Target lesions |
|
|
|
|
|
Baseline | 1 | 15 | 3 | 4 | 51 |
1st assessment | 1 | 12 | 3 | 2 | 42 |
2nd assessment | 1 | 11 | 0 | 0 | 41 |
Non-target lesions |
|
|
|
|
|
Baseline | 0 | 4 | 2 | 0 | 30 |
1st assessment | 0 | 3 | 1 | 0 | 22 |
2nd assessment | 0 | 6 | 1 | 0 | 14 |
New lesions |
|
|
|
|
|
1st assessment | 0 | 1 | 1 | 0 | 9 |
2nd assessment | 0 | 12 | 1 | 0 | 16 |